These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 832264

  • 61. Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations.
    Romani L, Nardelli B, Bianchi R, Puccetti P, Mage M, Fioretti MC.
    Int J Cancer; 1985 May 15; 35(5):659-65. PubMed ID: 3888855
    [Abstract] [Full Text] [Related]

  • 62. Site-dependent differences in rejection of tumor cells with and without preimmunization.
    den Otter W, Runhaar BA, Ruitenbeek A, Dullens HF.
    Eur J Immunol; 1974 Jun 15; 4(6):444-6. PubMed ID: 4471634
    [No Abstract] [Full Text] [Related]

  • 63. Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724).
    Houchens DP, Iorio A, Barzi A, Goldin A, Bonmassar E.
    Cancer Chemother Rep; 1975 Jun 15; 59(5):967-73. PubMed ID: 1203899
    [Abstract] [Full Text] [Related]

  • 64. Antitumor action of interferon: animal systems.
    Chirigos MA.
    Tex Rep Biol Med; 1977 Jun 15; 35():399-405. PubMed ID: 29359
    [No Abstract] [Full Text] [Related]

  • 65. Serological studies in mice bearing an allogeneic tumor.
    Davel L, Salmerón MY, Braun M, Pasqualini CD.
    Cell Mol Biol Incl Cyto Enzymol; 1980 Jun 15; 26(2):197-200. PubMed ID: 7008943
    [No Abstract] [Full Text] [Related]

  • 66. Immunological enhancement of a murine allogeneic tumor in absence of the spleen.
    Colmerauer ME, Pasqualine CD.
    Cell Immunol; 1975 Dec 15; 20(2):327-9. PubMed ID: 1203990
    [No Abstract] [Full Text] [Related]

  • 67. Identification of a variant of gross leukemia virus that induces disease in mice inoculated as adults.
    Wolfe JH, Blank KJ.
    J Exp Med; 1983 Aug 01; 158(2):629-34. PubMed ID: 6886626
    [Abstract] [Full Text] [Related]

  • 68. Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice.
    Riccardi C, Fioretti MC, Giampietri A, Puccetti P, Goldin A, Bonmassar E.
    J Natl Cancer Inst; 1978 May 01; 60(5):1083-90. PubMed ID: 642028
    [No Abstract] [Full Text] [Related]

  • 69. Allogeneic inhibition of transplanted tumor cells.
    Hellström KE, Hellström I.
    Prog Exp Tumor Res; 1967 May 01; 9():40-76. PubMed ID: 4863163
    [No Abstract] [Full Text] [Related]

  • 70. Immunological analysis of N-nitrosourea-induced rat leukemia and experimental trials for therapy of human leukemia.
    Imamura N, Okada K.
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec 01; 45(7):1307-13. PubMed ID: 7168310
    [No Abstract] [Full Text] [Related]

  • 71. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice.
    Ohsugi Y, Gershwin ME, Owens RB, Nelson-Rees WA.
    J Natl Cancer Inst; 1980 Oct 01; 65(4):715-8. PubMed ID: 6932523
    [Abstract] [Full Text] [Related]

  • 72. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.
    Herberman RB, Nunn ME, Holden HT, Staal S, Djeu JY.
    Int J Cancer; 1977 Apr 15; 19(4):555-64. PubMed ID: 844921
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo.
    Silvestrini R, Testorelli C, Goldin A, Nicolin A.
    Int J Cancer; 1977 May 15; 19(5):664-9. PubMed ID: 863544
    [Abstract] [Full Text] [Related]

  • 75. Ability of spleen cells from tumor bearing mice to transfer immunologic memory.
    Plavsić B, Jurin M, Ugarković B.
    Acta Radiol Oncol; 1983 May 15; 22(5):385-8. PubMed ID: 6320597
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition.
    Bonmassar E, Houchens DP, Fioretti MC, Goldin A.
    Chemotherapy; 1975 May 15; 21(6):321-9. PubMed ID: 1183242
    [Abstract] [Full Text] [Related]

  • 78. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.
    Kiessling R, Petranyi G, Klein G, Wigzel H.
    Int J Cancer; 1975 Jun 15; 15(6):933-40. PubMed ID: 1150347
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Enhancement of heterotransplanted human tumor graft survival in nude mice treated with antilymphocyte serum and in congenitally athymic-asplenic (Lasat) mice.
    Gershwin ME, Ikeda RM, Erickson K, Owens R.
    J Natl Cancer Inst; 1978 Jul 15; 61(1):245-8. PubMed ID: 276631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.